Dapagliflozin and metformin combo well-tolerated and associated with decreased risk of adverse events: Study
A study published in Diabetes Research and Clinical Practice suggests that dapagliflozin and metformin are well-tolerated and associated with a decreased risk of adverse events. DONATE (NCT03156985) is a large-scale real-world study investigating the …